Market Share of Global Oncology Clinical Trials Industry
The oncology clinical trials market is fragmented and competitive. The major pharmaceutical companies are found to make enormous investments in R&D, especially in emerging nations, to gain opportunities for market growth in the major regions. The strategic partnerships between pharmaceutical companies and CROs are expected to have a significant impact on the market's growth. Some major market players include Novartis AG, Merck & Co. Inc., Bristol Myers Squibb Company, F Hoffmann-La Roche Ltd, and Pfizer Inc.
Oncology Clinical Trial Market Leaders
Novartis AG
Merck & Co Inc.
F Hoffmann-La Roche Ltd
Pfizer Inc.
Bristol Myers Squibb Company
*Disclaimer: Major Players sorted in no particular order
